Active	Status	Sponsor type	Region	Phase	Filter
9 Active 29 Inactive 38 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Lee, Fa-Chyi
GRANITE, NCT05141721: A Study of a Patient-Specific Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer	Active, not recruiting	2/3	700	US	GRT-C901, GRT-R902, Atezolizumab, Tecentriq, Ipilimumab, Yervoy, Fluoropyrimidine plus leucovorin, Xeloda, Bevacizumab, Avastin	Gritstone bio, Inc.	Colorectal Neoplasms	03/27	03/27
ASIST, NCT05322590: BXQ-350 in Newly Diagnosed Metastatic Colorectal Carcinoma	Active, not recruiting	1/2	195	US	BXQ-350, SapC-DOPS, Placebo	Bexion Pharmaceuticals, Inc., ICON plc, CTI Clinical Trial and Consulting Services	Metastatic Colorectal Carcinoma, Neuropathy	04/26	04/29
Verschraegen, Claire
Neo-DREAM, NCT03567889 / 2021-003064-27: Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C Melanoma Patients	Recruiting	3	186	Europe, US	Daromun, Surgery, Adjuvant therapy	Philogen S.p.A., Philogen S.p.A.	Melanoma Stage IIIB/C	06/24	06/26
ARTACUS, NCT04349436: A Phase 1B/2 Study of RP1 in Solid Organ Transplant Patients With Advanced Cutaneous Malignancies	Recruiting	1/2	65	US	RP1, intra-tumoral injection, oncolytic virus	Replimune Inc.	Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma, Basal Cell Carcinoma, Melanoma	09/27	01/28